• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Robert Langreth

Stay informed with Robert Langreth’s coverage and analysis.

J&J says COVID booster dose provides 100% protection against severe disease
HealthJ&J says COVID booster dose provides 100% protection against severe disease
By Robert Langreth and BloombergSeptember 21, 2021
Pfizer headquarters
HealthFDA panel recommends COVID-19 boosters only for those 65 and older or at high risk
By Robert Langreth, Fiona Rutherford and BloombergSeptember 17, 2021
Moderna files for FDA authorization for a third-dose COVID booster shot
HealthModerna files for FDA authorization for a third-dose COVID booster shot
By Robert Langreth and BloombergSeptember 2, 2021
Pfizer submits early data on the effects of third booster dose to FDA
HealthPfizer submits early data on the effects of third booster dose to FDA
By Riley Griffin, Robert Langreth and BloombergAugust 16, 2021
FDA to green-light a third COVID shot for those with compromised immune system
HealthFDA to green-light a third COVID shot for those with compromised immune system
By Robert Langreth, Josh Wingrove and BloombergAugust 12, 2021
Moderna plans to build a vaccine factory in Canada that produces COVID shots
HealthModerna plans to build a vaccine factory in Canada that produces COVID shots
By Robert Langreth and BloombergAugust 10, 2021
Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
FinanceEli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
By Robert Langreth and BloombergAugust 3, 2021
How COVID-19 came raging back in 2021
HealthHow COVID-19 came raging back in 2021
By James Paton, Robert Langreth and BloombergJuly 27, 2021
Pfizer vaccine
HealthPfizer will seek FDA approval of a COVID vaccine booster shot in August
By Robert Langreth and BloombergJuly 8, 2021
Early coronavirus samples were removed from a U.S. database at the request of Chinese researchers
HealthEarly coronavirus samples were removed from a U.S. database at the request of Chinese researchers
By Rachel Chang, Robert Langreth and BloombergJune 24, 2021
Moderna COVID vaccine up to 100% effective in teens
HealthModerna COVID vaccine up to 100% effective in teens
By Robert Langreth and BloombergMay 25, 2021
Novavax shares soar after strong trial results for COVID-19 vaccine
HealthNovavax shares soar after strong trial results for COVID-19 vaccine
By Bloomberg and Robert LangrethJanuary 29, 2021
Moderna raises 2021 vaccine output outlook to at least 600 million doses
HealthModerna raises 2021 vaccine output outlook to at least 600 million doses
By Robert Langreth and BloombergJanuary 4, 2021
Moderna vaccine cleared in U.S., boosting immunization effort
HealthModerna vaccine cleared in U.S., boosting immunization effort
By Anna Edney, Robert Langreth and BloombergDecember 18, 2020
Moderna to request clearance for COVID-19 vaccine in U.S. and EU
HealthModerna to request clearance for COVID-19 vaccine in U.S. and EU
By Bloomberg and Robert LangrethNovember 30, 2020
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and countingplaceholder alt text
By Jacqueline MunisJune 24, 2026
Personal Finance
Current price of oil as of June 23, 2026placeholder alt text
By Joseph HostetlerJune 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.